| Title: | Frailty status and mortality among patients with cardiometabolic diseases in an international multi-cohort study |
| Journal: | iScience |
| Published: | 8 Apr 2026 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/42058915/ |
| DOI: | https://doi.org/10.1016/j.isci.2026.115615 |
Publication 18058
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Frailty is an indicator of biological aging associated with adverse outcomes in cardiometabolic diseases (CMD). We investigated the association between frailty status and mortality risk using data from five prospective cohorts including the UK Biobank, NHANES, CHARLS, ELSA, and HRS. Across these cohorts, pre-frail participants had a 21%-66% higher risk of all-cause mortality, while frail participants had a 54%-132% higher risk compared with non-frail individuals. Frailty was also associated with increased risks of cardiovascular and non-cardiovascular mortality, while associations with cancer-related mortality were mainly observed among individuals classified as frail. Subgroup analyses revealed heterogeneity across age, body mass index (BMI), sex, and CMD burden, with stronger associations among younger individuals (<65 years), those with lower BMI, and individuals with multiple CMDs. Sensitivity analyses yielded consistent results. These findings suggest that frailty may serve as an important prognostic marker in CMD populations and support risk stratification in clinical management.</p>
9 Authors
- Rui Ren
- Yao Zhang
- Meilin Du
- Wenxu Wang
- Liying Wang
- Jilong Bai
- Yibin Lu
- Yanan Ma
- Difei Wang
1 Application
| Application ID | Title |
|---|---|
| 147427 | Study of Multifactorial Effects on Aging and Diseases in the Elderly Population and Construction of a Population-based Early Aging Warning Model |
Enabling scientific discoveries that improve human health